PI16 and hepatocellular carcinoma: PI16 is upregulated in HCC tissues; PI16 knockdown sensitizes HCC cells to sorafenib treatment in vitro and in vivo; PI16 may serve as a predictive marker for sorafenib‐treated patients after resection.